Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

TherapeuticsMD - 17 Year Stock Price History | TXMD

Historical daily share price chart and data for TherapeuticsMD since 2007 adjusted for splits and dividends. The latest closing stock price for TherapeuticsMD as of May 07, 2024 is 1.96.
  • The all-time high TherapeuticsMD stock closing price was 8000.00 on February 02, 2010.
  • The TherapeuticsMD 52-week high stock price is 4.72, which is 140.8% above the current share price.
  • The TherapeuticsMD 52-week low stock price is 1.84, which is 6.1% below the current share price.
  • The average TherapeuticsMD stock price for the last 52 weeks is 2.93.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
TherapeuticsMD Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 2.2181 2.3300 2.6900 1.8600 1.9600 -12.89%
2023 3.7246 6.2500 6.2500 2.0000 2.2500 -59.75%
2022 9.7855 19.6800 21.8800 2.0700 5.5900 -68.55%
2021 52.9719 62.0000 127.5000 17.7750 17.7750 -70.62%
2020 76.2238 122.0000 140.5000 43.4500 60.5000 -50.00%
2019 181.1716 194.0000 299.5000 93.5000 121.0000 -36.48%
2018 284.1833 313.5000 371.0000 178.0000 190.5000 -36.92%
2017 281.7390 298.5000 404.5000 192.0000 302.0000 4.68%
2016 357.4663 490.5000 490.5000 236.0000 288.5000 -44.36%
2015 331.3333 219.5000 550.0000 203.0000 518.5000 133.03%
2014 249.0675 249.5000 398.5000 171.5000 222.5000 -14.59%
2013 155.2124 162.5000 270.5000 85.0000 260.5000 68.06%
2012 134.1850 85.0000 175.0000 80.0000 155.0000 106.67%
2011 131.9940 155.0000 500.0000 0.5000 75.0000 -50.00%
2010 3231.1111 7500.0000 8000.0000 150.0000 150.0000 -97.69%
2009 3608.5317 2500.0000 7750.0000 850.0000 6500.0000 160.00%
2008 2134.5850 1683.3333 3666.6667 850.0000 2500.0000 48.51%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.023B $0.001B
TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.722B 30.79
Chugai Pharmaceutical (CHGCY) Japan $54.827B 24.51
Takeda Pharmaceutical (TAK) Japan $42.282B 6.85
Merck (MKGAF) Germany $21.034B 19.85
Astellas Pharma (ALPMY) Japan $18.212B 28.75
Sandoz Group AG (SDZNY) Switzerland $14.757B 0.00
Neurocrine Biosciences (NBIX) United States $14.261B 39.04
Shionogi (SGIOY) Japan $14.151B 12.69
United Therapeutics (UTHR) United States $11.555B 12.32
Catalent (CTLT) United States $10.202B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.721B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.925B 7.61
Revolution Medicines (RVMD) United States $6.658B 0.00
Ionis Pharmaceuticals (IONS) United States $6.162B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.014B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.662B 0.00
Summit Therapeutics (SMMT) United States $3.138B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.117B 0.00
PTC Therapeutics (PTCT) United States $2.528B 0.00
Indivior (INDV) United States $2.503B 11.86
Corcept Therapeutics (CORT) United States $2.496B 22.61
Dyne Therapeutics (DYN) United States $2.294B 0.00
Ardelyx (ARDX) United States $2.141B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.098B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.042B 11.67
NewAmsterdam Pharma (NAMS) Netherlands $1.951B 0.00
Evotec AG (EVO) Germany $1.843B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.769B 18.28
Avadel Pharmaceuticals (AVDL) Ireland $1.687B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.597B 27.95
Soleno Therapeutics (SLNO) United States $1.535B 0.00
Xencor (XNCR) United States $1.499B 0.00
4D Molecular Therapeutics (FDMT) United States $1.369B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.269B 11.93
Pacira BioSciences (PCRX) United States $1.233B 12.27
Collegium Pharmaceutical (COLL) United States $1.211B 7.45
BioCryst Pharmaceuticals (BCRX) United States $1.087B 0.00
Enliven Therapeutics (ELVN) United States $1.077B 0.00
Cronos Group (CRON) Canada $1.012B 0.00
Relay Therapeutics (RLAY) United States $0.937B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.932B 0.00
Cassava Sciences (SAVA) United States $0.931B 0.00
ARS Pharmaceuticals (SPRY) United States $0.916B 0.00
Ocular Therapeutix (OCUL) United States $0.897B 0.00
USANA Health Sciences (USNA) United States $0.857B 13.90
Sage Therapeutics (SAGE) United States $0.797B 0.00
Siga Technologies (SIGA) United States $0.739B 10.94
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.736B 0.00
Savara (SVRA) United States $0.684B 0.00
Silence Therapeutics (SLN) United Kingdom $0.655B 0.00
Lyell Immunopharma (LYEL) United States $0.648B 0.00
Exscientia (EXAI) United Kingdom $0.604B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.600B 0.00
OmniAb (OABI) United States $0.552B 0.00
Verve Therapeutics (VERV) United States $0.538B 0.00
Larimar Therapeutics (LRMR) United States $0.526B 0.00
Altimmune (ALT) United States $0.522B 0.00
ProKidney (PROK) United States $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.512B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.466B 0.00
Korro Bio (KRRO) United States $0.453B 0.00
Lexeo Therapeutics (LXEO) United States $0.435B 0.00
Heron Therapeutics (HRTX) United States $0.428B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.408B 0.00
Esperion Therapeutics (ESPR) United States $0.402B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Black Diamond Therapeutics (BDTX) United States $0.388B 0.00
Harrow (HROW) United States $0.371B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 20.10
Aquestive Therapeutics (AQST) United States $0.319B 0.00
Bioventus (BVS) United States $0.317B 0.00
Organogenesis (ORGO) United States $0.315B 59.75
Akebia Therapeutics (AKBA) United States $0.312B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.310B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.309B 0.00
ESSA Pharma (EPIX) Canada $0.309B 0.00
Fractyl Health (GUTS) United States $0.304B 0.00
Nektar Therapeutics (NKTR) United States $0.303B 0.00
Nanobiotix S.A (NBTX) France $0.298B 0.00
Xeris Biopharma Holdings (XERS) United States $0.281B 0.00
Pyxis Oncology (PYXS) United States $0.254B 0.00
Adherex Technologies (FENC) United States $0.248B 0.00
Foghorn Therapeutics (FHTX) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.245B 0.00
Metagenomi (MGX) United States $0.242B 0.00
Eliem Therapeutics (ELYM) United States $0.240B 0.00
Avita Medical (RCEL) United States $0.230B 0.00
Conduit Pharmaceuticals (CDT) United States $0.227B 0.00
Zevra Therapeutics (ZVRA) United States $0.224B 0.00
Galectin Therapeutics (GALT) United States $0.215B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.214B 0.00
Century Therapeutics (IPSC) United States $0.205B 0.00
Acrivon Therapeutics (ACRV) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
MediWound (MDWD) Israel $0.179B 0.00
Telomir Pharmaceuticals (TELO) United States $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.171B 0.00
Prelude Therapeutics (PRLD) United States $0.161B 0.00
Regulus Therapeutics (RGLS) United States $0.159B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Elite Pharmaceuticals (ELTP) United States $0.153B 14.35
CytoDyn (CYDY) United States $0.150B 0.00
Incannex Healthcare (IXHL) Australia $0.147B 0.00
Cardiol Therapeutics (CRDL) Canada $0.138B 0.00
VAXART, INC (VXRT) United States $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.135B 2.84
Karyopharm Therapeutics (KPTI) United States $0.134B 0.00
OptiNose (OPTN) United States $0.129B 0.00
Inotiv (NOTV) United States $0.123B 0.00
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Assertio Holdings (ASRT) United States $0.116B 5.30
FibroGen (FGEN) United States $0.115B 0.00
Citius Pharmaceuticals (CTXR) United States $0.111B 0.00
PMV Pharmaceuticals (PMVP) United States $0.108B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
ProPhase Labs (PRPH) United States $0.096B 0.00
Aclaris Therapeutics (ACRS) United States $0.093B 0.00
AlloVir (ALVR) United States $0.093B 0.00
Jaguar Animal Health (JAGX) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Tempest Therapeutics (TPST) United States $0.083B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.082B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.081B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Carisma Therapeutics (CARM) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.97
Mural Oncology (MURA) Ireland $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.057B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Unicycive Therapeutics (UNCY) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
DURECT (DRRX) United States $0.037B 0.00
JanOne (JAN) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Surrozen (SRZN) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.032B 0.00
Lyra Therapeutics (LYRA) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Oncternal Therapeutics (ONCT) United States $0.027B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
PolyPid (PYPD) Israel $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.20
MEI Pharma (MEIP) United States $0.021B 1.08
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Acutus Medical (AFIB) United States $0.003B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.40
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.02